Serial Number | 79403149 |
Word Mark | QUBIT PHARMACEUTICALS |
Filing Date | Monday, April 22, 2024 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Monday, June 16, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, July 8, 2025 |
Description of Mark | The mark consists of the wording "QUBIT PHARMACEUTICALS" in stylized font placed to the left of a stylized cross design. |
Goods and Services | Downloadable and recorded computer software using artificial intelligence for visualization and modeling of molecules, molecular interactions, drug discovery, simulation of drug-target binding, and for the analysis of biomedical datasets; data acquisition and processing apparatus;; downloadable applications for mobile devices for visualization and modeling of molecules, molecular interactions, drug discovery, simulation of drug-target binding, and for the analysis of biomedical datasets; electronic databases recorded on computer media for use in the fields of cosmetics, health, medicine, pharmacology and the treatment of illnesses; data files in electronic format, downloadable, namely data sets containing data concerning cosmetics, health, medicine, pharmacology and the treatment of illnesses; scientific, technological and educational data sets in electronic form, downloadable; downloadable sound, video and audiovisual recordings featuring scientific, technological and educational information in the fields of cosmetics, health, medicine, pharmacology and the treatment of illnesses; downloadable and recorded software for conducting research; downloadable and recorded artificial intelligence and machine learning software for conducting scientific research in the cosmetic and medical fields; downloadable and recorded software for streaming scientific and technological content via the Internet and global communication networks; downloadable and recorded software for disseminating scientific and technological content to mobile digital electronic devices; downloadable and recorded scientific intelligence and monitoring software for visualization and modeling of molecules, molecular interactions, drug discovery, simulation of drug-target binding, and for the analysis of biomedical datasets; downloadable and recorded software for scientific and technological data research; downloadable computer software and applications using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in the development of pharmaceuticals; downloadable and recorded computer software, computer programs featuring algorithms for manipulating data input or received; data processing equipment; downloadable and recorded software for decision-making support; downloadable and recorded software for data analysis in the fields of cosmetics, health, medicine, pharmacology and the treatment of illnesses; downloadable and recorded software for data aggregation, analysis and processing integrating a collective work environment and for shared work and shared use of resources and data; downloadable and recorded software for planning, performing, integrating, optimizing and monitoring the research and development of new products, particularly new drugs; downloadable and recorded computer simulation software for planning, performance, integration, optimization and tracking of research and development of new products, particularly new drugs; downloadable and recorded collaborative software platforms for collaboration management, particularly in the scientific and technical fields; downloadable electronic publications, namely, research articles, scientific journals, white papers, reports, and conference proceedings featuring quantum computing applications, and artificial intelligence (AI) methodologies for research; all of the aforesaid goods being for use in connection with or relating to scientific research and research in the medical and pharmaceutical fields. |
Goods and Services | Transmission of information and data by electronic communication networks; rental of access time to users of computer programs on data networks; rental of access time to platforms on the Internet enabling the consultation, analysis, exchange and sharing of data; rental of access time to databases in global computer networks; all the aforesaid services provided in connection with or relating to scientific research and the pharmaceutical and medical field. |
Goods and Services | Collection of information, particularly commercial and scientific information, namely, compilation of scientific, cosmetic, health, medical and pharmacology information into computer databases for business purposes; collection of data, namely, commercial, scientific, cosmetic and health data, for business purposes; Providing consumer product information to customers via the Internet; computerized database management; management of computerized files and records of molecules and formulations for medical and pharmaceutical use, as well as medicines and medical and pharmaceutical research; provision of business information services relating to data processing; providing commercial information from on-line databases; organization of business meetings, namely, business meeting planning for establishing commercial collaborations; computer data processing services; compilation of statistical data relating to medical research for business purposes; business networking services, namely, arranging and commercial management of business collaborations; business project management with respect to commercial business, featuring business research and business development collaborations; compilation of scientific and technical information into computer databases; business information and advice concerning all the aforesaid services; all the aforesaid services provided in connection with or relating to scientific research and the pharmaceutical and medical fields. |
NOT AVAILABLE | "PHARMACEUTICALS" |
Goods and Services | Scientific research and scientific analysis of molecules in the field of developing cosmetics and treatments and medicines; medical research services, namely, computerized testing and analysis of medical compounds, medicines and molecules with the purpose of discovering new treatments or improving and optimizing of existing treatments; design of technical and scientific studies, namely, design, and planning of scientific research studies; design, development, programming, configuration, installation, maintenance, updating and testing of algorithms and computer software, particularly for artificial intelligence, molecular modelling and molecular interactions modeling, and decision support; design, development, programming, configuration, installation, maintenance, updating and testing of algorithms and computer software and platforms that are used for consulting, analyzing, exchanging and sharing data, particularly in a collaborative work environment, for use in the fields of cosmetics, health, medicine, pharmacology and the treatment of illnesses; design, development, composition, updating and testing of new medicines and new medicine formulas all being scientific research; medical and scientific research for the development of pharmaceutical products for medical or veterinary use; computer database design and development, namely, designing databases for use in the fields of health, medicine, pharmacology and the treatment of illnesses; design of computer databases; development of computer platforms; scientific and technical project study being scientific study and research in the fields of medicine, pharmacology and the treatment of illnesses; conducting of engineering surveys; design, development and programming of artificial intelligence software for use in the fields of health, medicine, pharmacology and the treatment of illnesses; software design and development for data capture, input, extraction, processing, display and storage systems; consultancy in connection with computer technology; development of computer programs, namely, decision support software; Software as a Service (SaaS) services featuring software for processing and analyzing data in the fields of health, medicine, pharmacology and the treatment of illnesses; computer project management in the field of electronic data processing; hosting of digital content, namely, of computer databases, for others, in the fields of cosmetic, health, medicine, pharmacology and the treatment of illnesses; rental of computer software in the fields of cosmetic, health, medicine, pharmacology and the treatment of illnesses; platform as a service (PaaS) featuring computer software platforms for high performance or quantum computing, for pharmaceutical, medical and scientific research; provision of information relating to scientific technology, namely scientific research information in the field of pharmaceuticals; provision of temporary use of non-downloadable software for data processing and analysis; preparation of technical and scientific reports, namely, providing technical and scientific information in the field of medical research; scientific research services; research and development services relating to the processing of medical data for third parties; computer programming services for data analysis; pharmaceutical and drug active ingredient discovery services; organizing, coordinating, conducting and monitoring scientific research in the field of cosmetics, health, medicine, pharmacology and the treatment of illnesses; advanced product research, design and development in the field of artificial intelligence; research in the field of quantum computing services applied to pharmaceutical, medical and scientific research; compiling data for scientific research purposes in the pharmaceutical and medical fields; drug discovery services; advisory and information services relating to the aforesaid services; all the aforesaid services provided in connection with or relating to scientific research and the medical field. |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, August 29, 2024 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 038 - Services allowing people to communicate with another by a sensory means. |
US Class Codes | 100, 101, 104 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, August 29, 2024 |
Primary Code | 038 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, August 29, 2024 |
Primary Code | 009 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, August 29, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | QUBIT PHARMACEUTICALS |
Party Type | 10 - Original Applicant |
Legal Entity Type | 34 - NOT AVAILABLE |
Address | FR |
Event Date | Event Description |
Thursday, August 29, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Tuesday, September 3, 2024 | APPLICATION FILING RECEIPT MAILED |
Monday, November 4, 2024 | ASSIGNED TO EXAMINER |
Tuesday, September 3, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, November 21, 2024 | NON-FINAL ACTION WRITTEN |
Friday, November 22, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Sunday, December 29, 2024 | REFUSAL PROCESSED BY IB |
Friday, March 14, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Friday, March 14, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Friday, March 14, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Friday, March 14, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Friday, March 14, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, April 3, 2025 | ASSIGNED TO EXAMINER |
Monday, May 5, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, May 5, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, May 5, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, June 3, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, December 6, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Friday, December 6, 2024 | REFUSAL PROCESSED BY MPU |